Overseas Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 1959.
1959 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Overseas Pharma Private Limited

Overseas Pharma Private Limited, a active private limited company, was established on 18 August 1959 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24119KA1959PTC001361. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 9 professional, Its leadership includes Nerendranath Venkatachala (Director), Manjula Krishnappa (Director), Thimmaiah Thimme Gowda (Director). Past directors included Nerendranath Venkatachala, Katapadi Shobha Shenoy, Manjula Krishnappa. It holds ₹5.17 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at No 941, First Floor, 21St Main, 22Nd Cross, Banashanakari Ii Stage,, Bangalore, Karnataka, 560070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24119KA1959PTC001361

  • Registration Number

    001361

  • Incorporation Date

    18 August 1959

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 66 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.17 Cr
  • Revenue Growth **** 10744.90%
  • Profit Growth **** 3543.07%
  • Ebitda **** 5690.29%
  • Net Worth 16116.63%
  • Total Assets **** 13653.50%
Company report

Overseas Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Overseas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Overseas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nerendranath Venkatachala Director 16 Jan 2017 Current
Manjula Krishnappa Director 16 Jan 2017 Current
Thimmaiah Thimme Gowda Director 05 Jan 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Whole-Time Director 16 Jan 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Managing Director 25 Oct 2010 Past
Pramod Abcsdd Managing Director 16 Jan 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Overseas Pharma.

Overseas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10744.9% increase. The company also saw a substantial improvement in profitability, with a 3543.07% increase in profit. The company's net worth Soared by an impressive increase of 16116.63%.

Overseas Pharma revenue growth over time
Overseas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10744.90%
*******
*******
*******
*******
Revenue from Operations
*******
 10970.32%
*******
*******
*******
*******
Total Assets
*******
 13653.50%
*******
*******
*******
*******
Profit or Loss
*******
 3543.07%
*******
*******
*******
*******
Net Worth
*******
 16116.63%
*******
*******
*******
*******
EBITDA
*******
 5690.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Overseas Pharma?

Unlock access to Overseas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹51,700,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 4.95 Cr
  • Canara Bank : 0.22 Cr
Latest Charge Details
Date Lender Amount Status
20 May 2025 Others ₹4.95 Cr Open
15 Feb 2021 Canara Bank ₹2.20 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Overseas Pharma?

Overseas Pharma has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Overseas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Overseas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Overseas Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Overseas Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Others amounted to Rs. 49.50 M with Charge ID 101098190 was registered on 20 May 2025. was recorded as a recent event.

  • Balance Sheet

    Overseas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Charges

    A charge with Canara Bank amounted to Rs. 2.20 M with Charge ID 100426825 was registered on 15 Feb 2021. was recorded as a recent event.

  • Director Appointment

    Progress on Nerendranath Venkatachala was appointed as a Director was appointed as a Director on 16 Jan 2017 & has been associated with this company since 9 years 28 days . was documented.

  • Director Appointment

    The activity Manjula Krishnappa was appointed as a Director was appointed as a Director on 16 Jan 2017 & has been associated with this company since 9 years 28 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Overseas Pharma Private Limited?

The CIN of Overseas Pharma Private Limited is U24119KA1959PTC001361.

Where is Overseas Pharma Private Limited headquartered?

Overseas Pharma Private Limited is headquartered at No 941, First Floor, 21St Main, 22Nd Cross, Banashanakari Ii Stage,, Bangalore, Karnataka, 560070.

When was Overseas Pharma Private Limited incorporated?

Overseas Pharma Private Limited was incorporated on 18 August 1959.

Who are the current directors of Overseas Pharma Private Limited?

The current directors of Overseas Pharma Private Limited are

What is the primary industry of Overseas Pharma Private Limited?

The primary industry of Overseas Pharma Private Limited is Manufacturing.

Is Overseas Pharma Private Limited a listed company?

Overseas Pharma Private Limited is unlisted.

What is the capital structure of Overseas Pharma Private Limited?

The authorized capital of Overseas Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Overseas Pharma Private Limited?

The compliance status of Overseas Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available